J Clin Invest 112(7):10491057
For weight management , certain GLP-1 formulations (liraglutide 3.0mg [Saxenda] and semaglutide 2.4mg [Wegovy]) are licensed for chronic weight management in adults with: BMI 30 kg/m , or BMI 27 kg/m with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, or dyslipidaemia) However, NHS access to these medications for weight management is typically restricted to specialist tier 3 or tier 4 weight management services, with specific eligibility criteria defined by NICE technology appraisals (TA494 for liraglutide, TA664 for semaglutide) and local commissioning arrangements
To inhibit the JNK pathway, H9c2 cells, and NMCMs were treated with SP 600125 (10 M, Tocris, #1496) for 30 min before applying other treatments as indicated in the figure legends
On Wednesday, the Texas Senate passed a bill that would ban all products containing THC, including gummies, vapes, flower, and beverages
Some people experience a slightly increased heart rate as a side effect of Wegovy